⌘K

Home/Filings/4/0001209191-21-042590

4//SEC Filing

Chen Ivan 4

Accession 0001209191-21-042590

CIK 0001006028other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 8:14 PM ET

Size

5.7 KB

Accession

0001209191-21-042590

Insider Transaction Report

Form 4

Period: 2021-06-18

PURE BIOSCIENCE, INC.PURE

Director

Transactions

Award
Stock Option (Right to Buy)
2021-06-18+125,000→ 125,000 total
Exercise: $0.45Exp: 2031-06-18→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

PURE BIOSCIENCE, INC.

CIK 0001006028

Entity typeother

Related Parties

1

filerCIK 0001743729

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 8:14 PM ET
Size: 5.7 KB

View on SEC.gov